The global cosmetic surgery products industry is on track for significant growth, with its value projected to rise from USD 19.09 billion in 2023 to an estimated USD 41.64 billion by 2033. This represents a robust compound annual growth rate (CAGR) of 8.1% during the forecast period, driven by an increasing focus on aesthetic procedures and technological advancements in the field of cosmetic surgery.
As demand for non-invasive and minimally invasive cosmetic procedures rises, there has been an increase in the adoption of advanced cosmetic surgery products, including dermal fillers, breast implants, and liposuction devices. The market is also benefiting from a growing desire for enhanced physical appearance among consumers, coupled with a rise in disposable income and improved access to cosmetic surgery services across emerging markets.
Technological innovations, such as the development of safer, more effective products and the integration of digital tools for planning and simulation, are expected to fuel continued market growth. Additionally, social media’s influence on beauty standards and the growing popularity of cosmetic enhancements are likely to contribute to sustained demand in the market.
Get Full Report Now – https://www.futuremarketinsights.com/reports/cosmetic-surgery-products-market
Key Takeaways:
- Market Growth: The global cosmetic surgery products market is projected to grow at a CAGR of 8.1%, reaching USD 41.64 billion by 2033.
- Key Drivers: Increasing consumer focus on aesthetic enhancement, technological advancements, and greater accessibility to cosmetic surgery products are fueling market expansion.
- Industry Trends: The growing popularity of non-invasive procedures, advanced product safety, and digital innovations are transforming the market landscape.
- Future Outlook: With rising consumer demand and continuous innovation, the market for cosmetic surgery products is expected to thrive, offering a range of transformative solutions for beauty and personal care.
The forecasted growth of the cosmetic surgery products market highlights the ongoing transformation within the beauty industry, as consumers increasingly seek safe, effective, and personalized solutions to enhance their appearance.
Factors Driving Market Growth
- Rising Popularity of Cosmetic Procedures: Increasing acceptance of cosmetic surgery across various demographics is driving demand for cosmetic surgery products.
- Influence of Social Media: The impact of social media and celebrity culture has heightened awareness and interest in aesthetic enhancements, prompting more individuals to seek cosmetic procedures.
- Advancements in Technology: Innovations in surgical techniques and non-invasive procedures are improving outcomes and safety, making cosmetic surgeries more appealing.
- Increased Incidence of Skin Conditions: The rising prevalence of skin-related issues is fueling the demand for cosmetic treatments aimed at enhancing appearance.
- Growing Investment in Healthcare Infrastructure: Enhanced healthcare facilities and access to skilled professionals are contributing to the expansion of the cosmetic surgery market.
Competition Analysis
Key players in the global cosmetic surgery products include Mentor Corporation, Allergan, Candela Corp, Lumenis Ltd., Cutera Inc, Palomar Medical, Iridex Corp, DermaMed Pharmaceutical Inc, Solta Medical, Medtronic plc, Syneron Medical Ltd., Johnson & Johnson Services, Inc. Cynosure Inc., and several others.
Key Updates from the Industry
- Apyx® Medical Corporation introduced the Apyx One Console, its latest-generation Renuvion generator, to the United States in January 2023. This state-of-the-art console boasts a multi-functional design, integrating an advanced 3-in-1 energy system that empowers plastic and cosmetic surgeons to utilize Renuvion technology alongside full monopolar and bipolar energy options.
- ZimVie made an announcement in November 2022 about the launch of their TSX implant in the United States. This implant represents the latest advancement in their range of surgical, restorative, and digital dentistry solutions. The TSX implants are specifically designed for immediate extraction and loading procedures, offering enhanced predictability and stability when placed in both soft and dense bone.
- Health Canada granted regulatory approval to Sientra’s breast implants in March 2022. The company plans to offer these breast implants in Canada by collaborating with its local partner, Kai Aesthetic. Under the distribution agreement, Sientra is committed to maintaining the utmost product quality, safety, and service standards, ensuring the well-being of patients and plastic surgeons alike.
- In March 2021, Iridex Corporation a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that it has entered into a strategic collaboration with Topcon Corporation. Topcon is a Japanese-based manufacturer and distributor with approximately US$ 1.3 Billion in annual revenues, including US$ 430 Million from its eye care business.
- In May 2020, AbbVie, announced that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by the Irish High Court.
Key Segments Profiled in the Global Cosmetic Surgery Products Market
By Product Type:
- Cosmetic Surgery Implants
- Breast Implants
- Chin & Cheek Implants
- Injectables
- Botulinum Toxin
- Soft Tissue Fillers
- Dermal Fillers
- Absorbable Fillers
- Non-Absorbable Fillers
- Cosmetic Surgery Lasers
- Ablative Laser
- Non-Ablative Laser
- Microdermabrators
- Liposuction Equipment
- Cosmetic Surgery Services
By Application:
- Face
- Upper Body
- Breasts
- Hands
- Stomach
- Lower Body
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Universities and Research Centers
- Homecare Settings
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
